Nasrulla Abdullaevich Shanazarov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nasrulla Abdullaevich Shanazarov has a total of 179 co-authors. Here are the top co-authors by number of shared publications:
- Andrey Avdeyev
Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan, Astana 010000, Kazakhstan
6 shared publications - Valery V. Benberin
Medical Centre Hospital of President’s Affairs Administration of the Republic of Kazakhstan, Nur-Sultan, KAZAKHSTAN
6 shared publications - Maxim S. Afanasiev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
4 shared publications - Sergey Viktorovich Zinchenko
Kazan Federal University
4 shared publications - Akmaral Khangeldi
Gynecology Department, NJSC “Astana Medical University”, Astana 010000, Kazakhstan
3 shared publications - Bakytzhan Bimbetov
Medical Centre Hospital of the President’s Affairs Administration of the Republic of Kazakhstan
3 shared publications
Latest Publications
- Open Access
Population-Specific Genetic Markers of Prostate Cancer Risk in Kazakh Men: Association Analysis of 102 SNPs and Risk Prediction Modeling
Background/Objectives: GWASs have identified more than 250 prostate cancer (PCa) predisposition loci, predominantly in European and partly Asian cohorts. The Kazakh population is markedly under-represented in international genetic studies, limiting existing risk models. This study aimed to analyze the distribution of 102 PCa-associated single-nucleotide polymorphism (SNP) genotypes and alleles and to identify reliable population-specific associations with PCa risk in Kazakh men. Methods: This retrospective case–control study included 941 Kazakh men (476 with histologically confirmed PCa and 465 cancer-free controls). Genomic DNA extracted from peripheral blood was genotyped with TaqMan® OpenArray® technology on a QuantStudio 12K Flex system. Associations were assessed by Pearson’s χ2 test and logistic regression, with genotypic and allelic odds ratios (OR) and 95% confidence intervals (CI). Two-step multiple-testing correction (Bonferroni and Benjamini–Hochberg false-discovery rate, FDR) was applied. Predictive models were built using classification and regression trees (CART) and stepwise logistic regression. Results: Of 102 SNPs, 39 showed nominally significant genotypic differences; 12 remained significant after Bonferroni correction and 2 after FDR (14 in total). Several of the corrected loci were significant at both the genotypic and allelic level. Allelic ORs ranged from 0.37 (protective rs10187424 T allele) to 4.81 (rs1545985). A parsimonious seven-SNP autosomal logistic-regression model achieved an apparent AuROC of 0.84 (10-fold cross-validated 0.82); adding age as a covariate raised discrimination to 0.87. Ten of the fourteen significant loci remained significant after age adjustment, and six of these formed a core signal robust to both age imbalance and genotyping-quality concerns. Conclusions: This first large-scale SNP-association study in Kazakh men shows allele-frequency profiles resembling East Asian rather than European populations, confirming the need for population-specific genetic risk-assessment tools. The seven-SNP model showed high discriminatory power in the training set and requires external validation before clinical application.
Open AccessPopulation-Specific Genetic Markers of Prostate Cancer Risk in Kazakh Men: Association Analysis of 102 SNPs and Risk Prediction Modeling
Background/Objectives: GWASs have identified more than 250 prostate cancer (PCa) predisposition loci, predominantly in European and partly Asian cohorts. The Kazakh population is markedly under-represented in international genetic studies, limiting existing risk models. This study aimed to analyze the distribution of 102 PCa-associated single-nucleotide polymorphism (SNP) genotypes and alleles and to identify reliable population-specific associations with PCa risk in Kazakh men. Methods: This retrospective case–control study included 941 Kazakh men (476 with histologically confirmed PCa and 465 cancer-free controls). Genomic DNA extracted from peripheral blood was genotyped with TaqMan® OpenArray® technology on a QuantStudio 12K Flex system. Associations were assessed by Pearson’s χ2 test and logistic regression, with genotypic and allelic odds ratios (OR) and 95% confidence intervals (CI). Two-step multiple-testing correction (Bonferroni and Benjamini–Hochberg false-discovery rate, FDR) was applied. Predictive models were built using classification and regression trees (CART) and stepwise logistic regression. Results: Of 102 SNPs, 39 showed nominally significant genotypic differences; 12 remained significant after Bonferroni correction and 2 after FDR (14 in total). Several of the corrected loci were significant at both the genotypic and allelic level. Allelic ORs ranged from 0.37 (protective rs10187424 T allele) to 4.81 (rs1545985). A parsimonious seven-SNP autosomal logistic-regression model achieved an apparent AuROC of 0.84 (10-fold cross-validated 0.82); adding age as a covariate raised discrimination to 0.87. Ten of the fourteen significant loci remained significant after age adjustment, and six of these formed a core signal robust to both age imbalance and genotyping-quality concerns. Conclusions: This first large-scale SNP-association study in Kazakh men shows allele-frequency profiles resembling East Asian rather than European populations, confirming the need for population-specific genetic risk-assessment tools. The seven-SNP model showed high discriminatory power in the training set and requires external validation before clinical application.
- Open Access
- 19 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1596
Photodynamic Therapy Efficacy of the Human Papillomavirus-Related Cervical Lesions
Background/Objectives: This study aims to fill certain knowledge gaps by assessing the clinical effectiveness of PDT in a large group of women with HPV-related cervical lesions and examining how different patient factors affect treatment results. Methods: A total of 811 women aged from 19 to 76 were retrospectively analyzed who were treated by PDT of HPV infection with atypical squamous cells and HPV-related cervical lesions. PDT was performed using chlorin e6-based systemic photosensitizers. Irradiation was carried out at 662 nm. The endocervical dose was 334 J/cm2, and the ectocervical dose was 291 J/cm2. Results: Overall HPV clearance was 91.1%, lesion remission was 95.3%, and complete response was 88.3%, with the highest complete response observed in the HSIL group compared with HPV-positive ASCs. Multivariable models showed that multiple HPV infection (especially >3 genotypes) and pregnancy history were associated with lower odds of complete response, while younger age (18–25 years) and TZ2 were associated with higher odds of complete response. Conclusions: PDT using chlorin e6-based photosensitizers demonstrated high clinical and virological effectiveness across HPV-related cervical abnormalities, including HSIL, supporting its role as an organ-preserving treatment option. Multiple HPV genotypes and pregnancy history may identify patients at increased risk of partial response and warrant closer follow-up or tailored treatment strategies.
- 19 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (4) , 1596
Open AccessPhotodynamic Therapy Efficacy of the Human Papillomavirus-Related Cervical Lesions
Background/Objectives: This study aims to fill certain knowledge gaps by assessing the clinical effectiveness of PDT in a large group of women with HPV-related cervical lesions and examining how different patient factors affect treatment results. Methods: A total of 811 women aged from 19 to 76 were retrospectively analyzed who were treated by PDT of HPV infection with atypical squamous cells and HPV-related cervical lesions. PDT was performed using chlorin e6-based systemic photosensitizers. Irradiation was carried out at 662 nm. The endocervical dose was 334 J/cm2, and the ectocervical dose was 291 J/cm2. Results: Overall HPV clearance was 91.1%, lesion remission was 95.3%, and complete response was 88.3%, with the highest complete response observed in the HSIL group compared with HPV-positive ASCs. Multivariable models showed that multiple HPV infection (especially >3 genotypes) and pregnancy history were associated with lower odds of complete response, while younger age (18–25 years) and TZ2 were associated with higher odds of complete response. Conclusions: PDT using chlorin e6-based photosensitizers demonstrated high clinical and virological effectiveness across HPV-related cervical abnormalities, including HSIL, supporting its role as an organ-preserving treatment option. Multiple HPV genotypes and pregnancy history may identify patients at increased risk of partial response and warrant closer follow-up or tailored treatment strategies.
- Open Access
- 26 December 2025
- Published by MDPI AG in Preprints.org
Photodynamic Therapy Efficacy of the Human Papillomavirus Related Cervical Lesions
Background/Objectives: This study aims to fill certain knowledge gaps by assessing the clinical effectiveness of PDT in a large group of women with HPV-related cervical lesions and examining how different patient factors affect treatment results. Methods: 811 women aged from 19 to 76 were retrospectively analyzed who were treated by PDT of HPV infection with atypical squamous cells and HPV-related cervical lesions. PDT was performed using chlorin e6–based systemic photosensitizers. Irradiation was carried out at 662 nm. The endocervical dose was 334 J/cm² and the ectocervical dose was 291 J/cm². Results: Overall HPV clearance was 91.1%, lesion remission 95.3%, and complete response 88.3%, with the highest complete response observed in the HSIL group compared with HPV-positive ASC. Multivariable models showed that multiple HPV infection (especially >3 genotypes) and pregnancy history were associated with lower odds of complete response, while younger age (18–25 years) and TZ2 were associated with higher odds of complete response. Conclusions: PDT using chlorin e6–based photosensitizers demonstrated high clinical and virological effectiveness across HPV-related cervical abnormalities, including HSIL, supporting its role as an organ-preserving treatment option. Multiple HPV genotypes and pregnancy history may identify patients at increased risk of incomplete response and warrant closer follow-up or tailored treatment strategies.
- 26 December 2025
- Published by MDPI AG in Preprints.org
Open AccessPhotodynamic Therapy Efficacy of the Human Papillomavirus Related Cervical Lesions
Background/Objectives: This study aims to fill certain knowledge gaps by assessing the clinical effectiveness of PDT in a large group of women with HPV-related cervical lesions and examining how different patient factors affect treatment results. Methods: 811 women aged from 19 to 76 were retrospectively analyzed who were treated by PDT of HPV infection with atypical squamous cells and HPV-related cervical lesions. PDT was performed using chlorin e6–based systemic photosensitizers. Irradiation was carried out at 662 nm. The endocervical dose was 334 J/cm² and the ectocervical dose was 291 J/cm². Results: Overall HPV clearance was 91.1%, lesion remission 95.3%, and complete response 88.3%, with the highest complete response observed in the HSIL group compared with HPV-positive ASC. Multivariable models showed that multiple HPV infection (especially >3 genotypes) and pregnancy history were associated with lower odds of complete response, while younger age (18–25 years) and TZ2 were associated with higher odds of complete response. Conclusions: PDT using chlorin e6–based photosensitizers demonstrated high clinical and virological effectiveness across HPV-related cervical abnormalities, including HSIL, supporting its role as an organ-preserving treatment option. Multiple HPV genotypes and pregnancy history may identify patients at increased risk of incomplete response and warrant closer follow-up or tailored treatment strategies.
- Open Access
- 1 July 2025
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 15 (2) , 83-89
Formation of Polybronchial Anastomosis in Central Lung Cancer with Bullous Changes Using Free Pericardial Fat Pad for Bronchial Suture Coverage: Clinical Case
Introduction. Bronchoplastic surgery with the formation of a polybronchial anastomosis in lung cancer allows bilobectomy or pneumonectomy to be avoided. Aim. This study evaluates the results of bronchoplastic surgery with polybronchial anastomosis formation in lung cancer treatment. Materials and methods. The minimum volume standards in surgery for patients in Russia and Kazakhstan are the right lower lobectomy. However, given the bullous changes observed in the right upper lobe and three remaining segments, this approach carries a risk of postoperative complications, including bulla rupture with fistula formation and pleural cavity infection. Consequently, we implemented an organ-sparing treatment strategy, which involved middle lobectomy, S6 segmentectomy, and sleeve resection of the intermediate, lower lobe, and B8 segmental bronchi, accompanied by the formation of polybronchial anastomosis between three bronchi. To prevent the development of bronchopleural fistula, we used a free pericardial fat pad. Results. The postoperative period was uneventful. At the 20-month follow-up, no recurrence was detected. Discussion. Bronchoplastic surgeries offer patients a better quality of life in comparison to pneumonectomy or bilobectomy, while maintaining equivalent recurrence-free survival rates as a radical treatment method. Conclusion. Bronchoplastic surgery is an effective approach for the treatment of lung cancer.
- 1 July 2025
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 15 (2) , 83-89
Open AccessFormation of Polybronchial Anastomosis in Central Lung Cancer with Bullous Changes Using Free Pericardial Fat Pad for Bronchial Suture Coverage: Clinical Case
Introduction. Bronchoplastic surgery with the formation of a polybronchial anastomosis in lung cancer allows bilobectomy or pneumonectomy to be avoided. Aim. This study evaluates the results of bronchoplastic surgery with polybronchial anastomosis formation in lung cancer treatment. Materials and methods. The minimum volume standards in surgery for patients in Russia and Kazakhstan are the right lower lobectomy. However, given the bullous changes observed in the right upper lobe and three remaining segments, this approach carries a risk of postoperative complications, including bulla rupture with fistula formation and pleural cavity infection. Consequently, we implemented an organ-sparing treatment strategy, which involved middle lobectomy, S6 segmentectomy, and sleeve resection of the intermediate, lower lobe, and B8 segmental bronchi, accompanied by the formation of polybronchial anastomosis between three bronchi. To prevent the development of bronchopleural fistula, we used a free pericardial fat pad. Results. The postoperative period was uneventful. At the 20-month follow-up, no recurrence was detected. Discussion. Bronchoplastic surgeries offer patients a better quality of life in comparison to pneumonectomy or bilobectomy, while maintaining equivalent recurrence-free survival rates as a radical treatment method. Conclusion. Bronchoplastic surgery is an effective approach for the treatment of lung cancer.
- Open Access
- 30 June 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 3(27),p. 53-63
EFFICACY OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF CERVICAL PRECANCEROUS CONDITIONS CAUSED BY HUMAN PAPILLOMAVIRUS
Relevance: PDT is a high-tech treatment that uses a combination of a photosensitizer, light and molecular oxygen. The method is based on the mechanisms of free radical oxidation, disruption of the vascular stroma of tumors and elimination under the influence of immune cells. It is a non-invasive, effective and safe treatment that damages and destroys structures in the affected area. However, to normalize the immune response, ensuring a stable regression of carcinogenesis, prolonged elimination of HPV is necessary. Aim: to assess the status of various levels of tissue damage in cervical dysplasia in combination with PVI, using PDT as the main method of treatment. Search strategy: In this study, indicators of the state of the organ, tissue, cellular and molecular levels are used to assess the course of PVI of the cervix. The role of the immune response in HPV-associated precancerous diseases of the cervix is considered. The article presents work on the treatment of dysplasia of varying degrees associated with HPV in 92 patients over a two-year period using PDT. Results: The use of photodynamic therapy in women with HPV-associated cervical precancerous disease is a promising area of research. The results of the work link the role of TLRs with the development of squamous intraepithelial lesions (SIL). Further clinical studies are needed to evaluate efficacy, safety and optimal timing. Актуальность: Фотодинамическая терапия (ФДТ) представляет собой неинвазивный высокотехнологичный метод лечения, основанный на взаимодействии фотосенсибилизатора, света определённой длины волны и молекулярного кислорода. Механизм действия ФДТ включает индукцию свободнорадикального окисления, нарушение сосудистой стромы опухоли и активацию иммунного ответа, направленного на элиминацию патологических клеток. Метод отличается высокой селективностью и безопасностью, обеспечивая прицельное разрушение поражённых тканей с минимальным повреждением здоровых структур. В то же время, при лечении опухолей, ассоциированных с вирусом папилломы человека (ВПЧ), для достижения стабильной регрессии патологического процесса требуется длительная и эффективная элиминация вируса, способствующая нормализации иммунного ответа и снижению риска рецидива. Цель:оценка показателей состояния различных уровней тканевого поражения при дисплазиях шейки матки в сочетании с ПВИ, с использованием ФДТ, в качестве основного метода лечения. Стратегия работы: В настоящем исследовании ФДТ применялась для терапии шейки матки при вирус-ассоциированных предраковых изменениях. Стратегия оценки эффективности лечения включала анализ показателей на органном, тканевом, клеточном и молекулярном уровнях. Особое внимание уделено роли иммунного ответа при ВПЧ-ассоциированных предраковых заболеваниях. Представлены результаты наблюдения за 92 пациентками с цервикальными дисплазиями различной степени тяжести в течение двух лет, получавшими лечение с использованием ФДТ. Результаты: Применение фотодинамической терапии (ФДТ) у женщин с ВПЧ-ассоциированными предопухолевыми заболеваниями шейки матки представляет собой перспективное направление клинических исследований. Полученные результаты свидетельствуют о потенциальной взаимосвязи между экспрессией Toll-подобных рецепторов (TLRs) и развитием плоскоклеточных интраэпителиальных поражений (SIL). Дальнейшие масштабные клинические исследования необходимы для уточнения эффективности, безопасности и оптимальных сроков применения ФДТ в данной категории пациентов. Өзектілігі: ФДТ – фотосенсибилизатор, жарықжәнемолекулалықоттегініңкомбинациясынпайдаланатынжоғарытехнологиялықемдеу. Әдісбосрадикалдытотығу, ісіктердіңтамырлыстромасыныңбұзылуыжәнеиммундықжасушалардыңәсеріненжойылумеханизмдеріненегізделген. Бұлзақымдалғанаймақтыинвазивтіемес, тиімдіжәнеқауіпсіземдеуәдісі. Дегенмен, иммундықжауаптықалыпқакелтіру,...
- 30 June 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 3(27),p. 53-63
Open AccessEFFICACY OF PHOTODYNAMIC THERAPY IN THE TREATMENT OF CERVICAL PRECANCEROUS CONDITIONS CAUSED BY HUMAN PAPILLOMAVIRUS
Relevance: PDT is a high-tech treatment that uses a combination of a photosensitizer, light and molecular oxygen. The method is based on the mechanisms of free radical oxidation, disruption of the vascular stroma of tumors and elimination under the influence of immune cells. It is a non-invasive, effective and safe treatment that damages and destroys structures in the affected area. However, to normalize the immune response, ensuring a stable regression of carcinogenesis, prolonged elimination of HPV is necessary. Aim: to assess the status of various levels of tissue damage in cervical dysplasia in combination with PVI, using PDT as the main method of treatment. Search strategy: In this study, indicators of the state of the organ, tissue, cellular and molecular levels are used to assess the course of PVI of the cervix. The role of the immune response in HPV-associated precancerous diseases of the cervix is considered. The article presents work on the treatment of dysplasia of varying degrees associated with HPV in 92 patients over a two-year period using PDT. Results: The use of photodynamic therapy in women with HPV-associated cervical precancerous disease is a promising area of research. The results of the work link the role of TLRs with the development of squamous intraepithelial lesions (SIL). Further clinical studies are needed to evaluate efficacy, safety and optimal timing. Актуальность: Фотодинамическая терапия (ФДТ) представляет собой неинвазивный высокотехнологичный метод лечения, основанный на взаимодействии фотосенсибилизатора, света определённой длины волны и молекулярного кислорода. Механизм действия ФДТ включает индукцию свободнорадикального окисления, нарушение сосудистой стромы опухоли и активацию иммунного ответа, направленного на элиминацию патологических клеток. Метод отличается высокой селективностью и безопасностью, обеспечивая прицельное разрушение поражённых тканей с минимальным повреждением здоровых структур. В то же время, при лечении опухолей, ассоциированных с вирусом папилломы человека (ВПЧ), для достижения стабильной регрессии патологического процесса требуется длительная и эффективная элиминация вируса, способствующая нормализации иммунного ответа и снижению риска рецидива. Цель:оценка показателей состояния различных уровней тканевого поражения при дисплазиях шейки матки в сочетании с ПВИ, с использованием ФДТ, в качестве основного метода лечения. Стратегия работы: В настоящем исследовании ФДТ применялась для терапии шейки матки при вирус-ассоциированных предраковых изменениях. Стратегия оценки эффективности лечения включала анализ показателей на органном, тканевом, клеточном и молекулярном уровнях. Особое внимание уделено роли иммунного ответа при ВПЧ-ассоциированных предраковых заболеваниях. Представлены результаты наблюдения за 92 пациентками с цервикальными дисплазиями различной степени тяжести в течение двух лет, получавшими лечение с использованием ФДТ. Результаты: Применение фотодинамической терапии (ФДТ) у женщин с ВПЧ-ассоциированными предопухолевыми заболеваниями шейки матки представляет собой перспективное направление клинических исследований. Полученные результаты свидетельствуют о потенциальной взаимосвязи между экспрессией Toll-подобных рецепторов (TLRs) и развитием плоскоклеточных интраэпителиальных поражений (SIL). Дальнейшие масштабные клинические исследования необходимы для уточнения эффективности, безопасности и оптимальных сроков применения ФДТ в данной категории пациентов. Өзектілігі: ФДТ – фотосенсибилизатор, жарықжәнемолекулалықоттегініңкомбинациясынпайдаланатынжоғарытехнологиялықемдеу. Әдісбосрадикалдытотығу, ісіктердіңтамырлыстромасыныңбұзылуыжәнеиммундықжасушалардыңәсеріненжойылумеханизмдеріненегізделген. Бұлзақымдалғанаймақтыинвазивтіемес, тиімдіжәнеқауіпсіземдеуәдісі. Дегенмен, иммундықжауаптықалыпқакелтіру,...
- Open Access
- 9 June 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (2) , 49-59
Modern methods of treatment of precancerous vulvar diseases, with a focus on photodynamic therapy: literature review
Комбинированная фотодинамическая терапия предопухолевых заболеваний вульвы: обзор литературы
- 9 June 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (2) , 49-59
Open AccessModern methods of treatment of precancerous vulvar diseases, with a focus on photodynamic therapy: literature review
Комбинированная фотодинамическая терапия предопухолевых заболеваний вульвы: обзор литературы
- Open Access
- 22 October 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6318
Risks of Cervical Cancer Recurrence After Fertility-Sparing Surgery and the Role of Human Papillomavirus Infection Types
Cervical cancer is a largely preventable malignancy of the uterine cervix. The tendencies in cervical cancer morbidity and mortality have remained similar for the past decade, albeit with increasing frequency in low- and middle-income countries (LMICs). Moreover, in the majority of LMICs, cervical cancer is the second most prevalent cancer and the second most common cause of cancer-related death among reproductive-age women. High-risk human papillomavirus (HR-HPV) infections have been proven to be associated with up to 95% of cervical cancer cases, with HPV-16 and HPV-18 types being responsible for approximately 70% of all cervical cancers, with the other high-risk HPV types accounting for up to a further 25%. More recently, the latest data appear to confirm there is a change in the frequency of HR-HPV occurrence, especially HPV-16 and HPV-18, as a reflection of the implementation of preventive vaccination programs. Owing to the growing incidence of cervical cancer among reproductive-age women and with the development of cancer management approaches, fertility-sparing options have been proposed for early-stage cervical cancer management as an option for young women, especially those with unaccomplished reproductive desires. However, methods applied for this purpose (cold-knife conization, loop electrosurgical excision, trachelectomy) have variable outcomes and do not prevent risks of relapse. Multiple factors are involved in cervical cancer recurrence, even in cases treated at the early stage of the disease. In this review, the authors unveil whether HPV infection and virus type could be one of the key factors associated with cervical cancer recurrence after fertility-sparing surgery. Reviews of the literature reveal that recurrent and persistent HR-HPV infection is a strong predictor of cervical lesions’ relapse. In particular, HPV-16 and HPV-18 infections and their persistence have been reported to be associated with cervical cancer recurrence. HR-HPV genotyping before and after fertility-sparing surgery for cervical cancer could facilitate a personalized approach and improve the overall survival rate. Screening for HR-HPV is essential during the follow-up of cervical cancer-treated women and will help to predict possible cancer recurrence.
- 22 October 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6318
Open AccessRisks of Cervical Cancer Recurrence After Fertility-Sparing Surgery and the Role of Human Papillomavirus Infection Types
Cervical cancer is a largely preventable malignancy of the uterine cervix. The tendencies in cervical cancer morbidity and mortality have remained similar for the past decade, albeit with increasing frequency in low- and middle-income countries (LMICs). Moreover, in the majority of LMICs, cervical cancer is the second most prevalent cancer and the second most common cause of cancer-related death among reproductive-age women. High-risk human papillomavirus (HR-HPV) infections have been proven to be associated with up to 95% of cervical cancer cases, with HPV-16 and HPV-18 types being responsible for approximately 70% of all cervical cancers, with the other high-risk HPV types accounting for up to a further 25%. More recently, the latest data appear to confirm there is a change in the frequency of HR-HPV occurrence, especially HPV-16 and HPV-18, as a reflection of the implementation of preventive vaccination programs. Owing to the growing incidence of cervical cancer among reproductive-age women and with the development of cancer management approaches, fertility-sparing options have been proposed for early-stage cervical cancer management as an option for young women, especially those with unaccomplished reproductive desires. However, methods applied for this purpose (cold-knife conization, loop electrosurgical excision, trachelectomy) have variable outcomes and do not prevent risks of relapse. Multiple factors are involved in cervical cancer recurrence, even in cases treated at the early stage of the disease. In this review, the authors unveil whether HPV infection and virus type could be one of the key factors associated with cervical cancer recurrence after fertility-sparing surgery. Reviews of the literature reveal that recurrent and persistent HR-HPV infection is a strong predictor of cervical lesions’ relapse. In particular, HPV-16 and HPV-18 infections and their persistence have been reported to be associated with cervical cancer recurrence. HR-HPV genotyping before and after fertility-sparing surgery for cervical cancer could facilitate a personalized approach and improve the overall survival rate. Screening for HR-HPV is essential during the follow-up of cervical cancer-treated women and will help to predict possible cancer recurrence.
- Open Access
- 25 April 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (9) , 889
Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus
The purpose of this article is to investigate the common facilitators and barriers associated with the implementation of hospital-based health technology assessment (HB-HTA) across diverse hospital settings in seven countries. Through a two-round Delphi study, insights were gathered from a panel of 15 HTA specialists from France, Hungary, Italy, Kazakhstan, Poland, Switzerland, and Ukraine. Experts initially conducted a comprehensive review of the HB-HTA implementation in their respective countries, identifying the barriers and facilitators through descriptive analysis. Subsequently, panel experts ranked these identified barriers and facilitators on a seven-point Likert scale. A median agreement score ≥ 6 and interquartile range (IQR) ≤ 1 was accepted as reaching a consensus. Out of the 12 statements categorized as external and internal barriers and facilitators, the expert panel reached consensus on six statements (two barriers and four facilitators). The external barrier, which achieved consensus, was the lack of the formal recognition of the role of HB-HTA in national or regional legislations. The internal barrier reaching consensus was the limited availability of human resources dedicated to HB-HTA. This qualitative study indicates that HB-HTA still has progress to make before being formally accepted and integrated across most countries, although by building on the facilitating factors we identified there may be an opportunity for the implementation of internationally developed strategies to strengthen HB-HTA practices.
- 25 April 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (9) , 889
Open AccessOvercoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus
The purpose of this article is to investigate the common facilitators and barriers associated with the implementation of hospital-based health technology assessment (HB-HTA) across diverse hospital settings in seven countries. Through a two-round Delphi study, insights were gathered from a panel of 15 HTA specialists from France, Hungary, Italy, Kazakhstan, Poland, Switzerland, and Ukraine. Experts initially conducted a comprehensive review of the HB-HTA implementation in their respective countries, identifying the barriers and facilitators through descriptive analysis. Subsequently, panel experts ranked these identified barriers and facilitators on a seven-point Likert scale. A median agreement score ≥ 6 and interquartile range (IQR) ≤ 1 was accepted as reaching a consensus. Out of the 12 statements categorized as external and internal barriers and facilitators, the expert panel reached consensus on six statements (two barriers and four facilitators). The external barrier, which achieved consensus, was the lack of the formal recognition of the role of HB-HTA in national or regional legislations. The internal barrier reaching consensus was the limited availability of human resources dedicated to HB-HTA. This qualitative study indicates that HB-HTA still has progress to make before being formally accepted and integrated across most countries, although by building on the facilitating factors we identified there may be an opportunity for the implementation of internationally developed strategies to strengthen HB-HTA practices.
- 29 March 2024
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 71 (1)
GENETIC MECHANISMS OF HEPATOCELLULAR CARCINOMA: LITERATURE REVIEW
Relevance: Hepatocellular carcinoma (HCC) is the most common form of primary liver malignancy. This form of liver cancer is characterized by rapid progression and poor survival prognosis. Understanding the genetic mechanisms that underlie HCC is of great importance for developing new diagnostic and therapeutic approaches. The purpose is to study the genetic factors in the development of hepatocellular carcinoma. Materials and methods: This review used various sources of literature, including scientific articles and reviews. We reviewed the results of scientific and clinical studies published in 2018-2023 and indexed in the PubMed, Cochrane library, Scopus and Web of Science databases, using the keywords “hepatocellular carcinoma,” “genes,” and “genetic predictors.” Inclusion of articles in the review was based on their content and relevance to the research topic. Results: Various genes associated with hepatocellular carcinoma were analyzed, including genes frequently mutated in HCC, as well as genes that play a role in the regulation of cell growth, apoptosis, metastasis, and invasion. Epigenetic changes such as DNA methylation and chromatin modifications have been investigated. The roles of microRNAs, long non-coding RNAs, circulating microparticles and other biomarkers in the diagnosis and prognosis of HCC were also reviewed. Conclusion: The materials and methods used in this review allowed us to cover a wide range of genes and molecular mechanisms associated with hepatocellular carcinoma. Understanding these mechanisms plays an important role in the development of new diagnostic and therapeutic approaches to combat this dangerous form of liver cancer. Further research in this area will help expand our knowledge base and improve the HCC treatment.
- 29 March 2024
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 71 (1)
GENETIC MECHANISMS OF HEPATOCELLULAR CARCINOMA: LITERATURE REVIEW
Relevance: Hepatocellular carcinoma (HCC) is the most common form of primary liver malignancy. This form of liver cancer is characterized by rapid progression and poor survival prognosis. Understanding the genetic mechanisms that underlie HCC is of great importance for developing new diagnostic and therapeutic approaches. The purpose is to study the genetic factors in the development of hepatocellular carcinoma. Materials and methods: This review used various sources of literature, including scientific articles and reviews. We reviewed the results of scientific and clinical studies published in 2018-2023 and indexed in the PubMed, Cochrane library, Scopus and Web of Science databases, using the keywords “hepatocellular carcinoma,” “genes,” and “genetic predictors.” Inclusion of articles in the review was based on their content and relevance to the research topic. Results: Various genes associated with hepatocellular carcinoma were analyzed, including genes frequently mutated in HCC, as well as genes that play a role in the regulation of cell growth, apoptosis, metastasis, and invasion. Epigenetic changes such as DNA methylation and chromatin modifications have been investigated. The roles of microRNAs, long non-coding RNAs, circulating microparticles and other biomarkers in the diagnosis and prognosis of HCC were also reviewed. Conclusion: The materials and methods used in this review allowed us to cover a wide range of genes and molecular mechanisms associated with hepatocellular carcinoma. Understanding these mechanisms plays an important role in the development of new diagnostic and therapeutic approaches to combat this dangerous form of liver cancer. Further research in this area will help expand our knowledge base and improve the HCC treatment.
- 29 December 2023
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 70 (4)
PHOTODYNAMIC THERAPY FOR CERVICAL CANCER: A LITERATURE REVIEW
Relevance: Cervical cancer is a major public health problem worldwide, with human papillomavirus infection playing a vital role as a risk factor. Photodynamic therapy is a minimally invasive treatment for HPV-related cervical lesions that uses photosensitizers and light to selectively destroy abnormal cells. The study aims to comprehensively review the different types of molecules used in PDT to reduce the morbidity and mortality associated with cervical cancer. Methods: A comprehensive search was conducted for all relevant articles investigating the efficacy and safety of PDT in the treatment of HPV-associated cervical cancer. PICO scores were determined for the review, and a literature search of the PubMed database was performed. An examination of the PubMed online database using keyword combinations identified 71 studies conducted between 2013 and 2023 that investigated using PDT to treat RSM cells. This article reviews ongoing clinical trials examining the efficacy of PDT in treating low-grade squamous cell intraepithelial neoplasia and high-grade squamous cell intraepithelial lesions, as well as preclinical approaches using different molecules for PDT in cervical cancer. Results: Potential molecules for PDT are described, their advantages and disadvantages evaluated, and solutions to improve their compatibility with antitumor treatment are proposed. Our review shows that PDT is a promising therapeutic approach for diagnosing and treating HPV-related cervical lesions. At the same time, we observe that using different classes of dyes enhances the anticancer effects of PDT. Conclusion: Fullerene and ALA-PDT are potential leaders for more intensive use in PDT, which will further help reduce the global incidence and mortality from cervical cancer. However, further studies are needed to evaluate its long-term efficacy and safety.
- 29 December 2023
- Published by Kazakh Institute of Oncology and Radiology in Oncologia i Radiologia Kazakhstana
- Vol. 70 (4)
PHOTODYNAMIC THERAPY FOR CERVICAL CANCER: A LITERATURE REVIEW
Relevance: Cervical cancer is a major public health problem worldwide, with human papillomavirus infection playing a vital role as a risk factor. Photodynamic therapy is a minimally invasive treatment for HPV-related cervical lesions that uses photosensitizers and light to selectively destroy abnormal cells. The study aims to comprehensively review the different types of molecules used in PDT to reduce the morbidity and mortality associated with cervical cancer. Methods: A comprehensive search was conducted for all relevant articles investigating the efficacy and safety of PDT in the treatment of HPV-associated cervical cancer. PICO scores were determined for the review, and a literature search of the PubMed database was performed. An examination of the PubMed online database using keyword combinations identified 71 studies conducted between 2013 and 2023 that investigated using PDT to treat RSM cells. This article reviews ongoing clinical trials examining the efficacy of PDT in treating low-grade squamous cell intraepithelial neoplasia and high-grade squamous cell intraepithelial lesions, as well as preclinical approaches using different molecules for PDT in cervical cancer. Results: Potential molecules for PDT are described, their advantages and disadvantages evaluated, and solutions to improve their compatibility with antitumor treatment are proposed. Our review shows that PDT is a promising therapeutic approach for diagnosing and treating HPV-related cervical lesions. At the same time, we observe that using different classes of dyes enhances the anticancer effects of PDT. Conclusion: Fullerene and ALA-PDT are potential leaders for more intensive use in PDT, which will further help reduce the global incidence and mortality from cervical cancer. However, further studies are needed to evaluate its long-term efficacy and safety.